2,629
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Clinical and molecular characteristics of myotonia congenita in China: Case series and a literature review

, , , , , , , & ORCID Icon show all
Pages 35-46 | Received 10 Jan 2022, Accepted 08 Feb 2022, Published online: 16 Feb 2022

References

  • Altamura C, Lucchiari S, Sahbani D, et al. The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel. Hum Mutat. 2018;39(9):1273–1283.
  • Trivedi JR, Bundy B, Statland J, et al. Non-dystrophic myotonia: prospective study of objective and patient reported outcomes. Brain. 2013;136(Pt 7):2189–2200.
  • Koch MC, Steinmeyer K, Lorenz C, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science. 1992;257(5071):797–800.
  • Yang X, Jia H, An R, et al. Sequence CLCN1 and SCN4A in patients with Nondystrophic myotonias in Chinese populations: genetic and pedigree analysis of 10 families and review of the literature. Channels (Austin). 2017;11(1):55–65.
  • Lossin C, George AL Jr. Myotonia congenita. Adv Genet. 2008;63:25–55.
  • Cherian A, Baheti NN, Kuruvilla A. Muscle channelopathies and electrophysiological approach. Ann Indian Acad Neurol. 2008;11(1):20–27.
  • Colding-Jorgensen E. Phenotypic variability in myotonia congenita. Muscle Nerve. 2005;32(1):19–34.
  • Plassart-Schiess E, Gervais A, Eymard B, et al. Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance. Neurology. 1998;50(4):1176–1179.
  • Hu C, Shi Y, Zhao L, et al. Myotonia congenita: clinical characteristic and mutation spectrum of CLCN1 in Chinese patients. Front Pediatr. 2021;9:759505.
  • Kuo HC, Hsiao KM, Chang LI, et al. Novel mutations at carboxyl terminus of CIC-1 channel in myotonia congenita. Acta Neurol Scand. 2006;113(5):342–346.
  • Gao F, Ma FC, Yuan ZF, et al. Novel chloride channel gene mutations in two unrelated Chinese families with myotonia congenita. Neurol India. 2010;58(5):743–746.
  • Ma FC, Gao F, and Yuan ZF. Clinical analysis and gene mutation screening of CLCN1 in two myotonia congenita families. J Clin Pediatr. 2011;29(11):1041–1043. Chinese.
  • Kong LN, Wu QY, and Shen YS, et al. Study of CLCN1 gene mutations in a family with myotonia congenital. J Clin Neurol. 2012;25(6):407–409. Chinese.
  • Li HF, Chen WJ, Ni W, et al. Paroxysmal kinesigenic dyskinesia and myotonia congenita in the same family: coexistence of a PRRT2 mutation and two CLCN1 mutations. Neurosci Bull. 2014;30(6):1010–1016.
  • Liu XL, Huang XJ, Shen JY, et al. Myotonia congenita: novel mutations in CLCN1 gene. Channels (Austin). 2015;9(5):292–298.
  • Gu P, Sun ZQ, Wang WT, et al. A case of myotonia congenita. J Chin J Nerv Ment Dis. 2017;43(6):377–378. Chinese.
  • Jing F, Li H, Yang D, et al. Analysis of CLCN1 gene mutations in a family affected with myotonia congenita. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018;35(3):400–402. Chinese.
  • Zhang W, Meng HX, Wang XM, et al. Identification of two novel compound heterozygous CLCN1 mutations associated with autosomal recessive myotonia congenita. Neurol Res. 2019;41(12):1069–1074.
  • Yang HJ, Zhao HJ, Yang XL. Clinical, electrophysiological, and genetic studies of one family and one sporadic patient with congenital myotonia. J Int Neurol Neurosurg. 2019;46(4):364–367. Chinese.
  • Zhao CY, Tang DF, and Huang H, et al. Myotonia congenita and periodic hypokalemia paralysis in a consanguineous marriage pedigree: coexistence of a novel CLCN1 mutation and an SCN4A mutation. PLoS One. 2020;15(5):e0233017.
  • Cao XL, Qin QY, Huang W. Clinical and genetic analysis for a family with myotonia congenita of CLCN1 gene mutations. Chin J Pract Nerv Dis. 2020;23(23):2112–2116. Chinese.
  • Su MX, Da YW, Yang BF, et al. A case report of young female with lowerlimnbs stiffness for 20 years, fatigue and weakness for 1 month-Myotonia congenita and Hoffmann syndrome. Chin J Nerv Ment Dis. 2020;46(12):759–762R. Chinese.
  • Song J, Zhang JW, Li G, et al. Clinical and genetic features of three Chinese patients with myotonia congenita. J Apoplexy Nervous Dis. 2021;38(3):249–252. Chinese.
  • Lehmann-Horn F, Rudel R, Ricker K. Non-dystrophic myotonias and periodic paralyses. A European neuromuscular center workshop held 4-6 October 1992, Ulm, Germany. Neuromuscul Disord. 1993;3(2):161–168.
  • Burgunder JM, Huifang S, Beguin P, et al. Novel chloride channel mutations leading to mild myotonia among Chinese. Neuromuscul Disord. 2008;18(8):633–640.
  • Jou SB, Chang LI, Pan H, et al. Novel CLCN1 mutations in Taiwanese patients with myotonia congenita. J Neurol. 2004;251(6):666–670.
  • Chen ZT, He J, and Chen WJ, et al. Analysis of CLCN1 gene mutations in 2 patients with myotonia congenita. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012;29(6):690–692. Chinese.
  • Fialho D, Kullmann DM, Hanna MG, et al. Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita. Neuromuscul Disord. 2008;18(11):869–872.
  • Vereb N, Montagnese F, Glaser D, et al. Non-dystrophic myotonias: clinical and mutation spectrum of 70 German patients. J Neurol. 2021;268(5):1708–1720.
  • Heatwole CR, Statland JM, Logigian EL. The diagnosis and treatment of myotonic disorders. Muscle Nerve. 2013;47(5):632–648.
  • Nojszewska M, Lusakowska A, Gawel M, et al. The needle EMG findings in myotonia congenita. J Electromyogr Kinesiol. 2019;49:102362.
  • Dupre N, Chrestian N, Bouchard JP, et al. Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians. Neuromuscul Disord. 2009;19(5):330–334.
  • Stunnenberg BC, Raaphorst J, Groenewoud HM, et al. Effect of mexiletine on muscle stiffness in patients with nondystrophic myotonia evaluated using aggregated N-of-1 trials. JAMA. 2018;320(22):2344–2353.
  • Andersen G, Hedermann G, Witting N, Andersen G, Hedermann G, Witting N, et al. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study. Brain. 2017;140(9):2295–2305.
  • Modoni A, D’Amico A, Primiano G, et al. Long-term safety and usefulness of mexiletine in a large cohort of patients affected by non-dystrophic myotonias. Front Neurol. 2020;11:300.
  • Orsini C, Petillo R, D’Ambrosio P, et al. CLCN1 molecular characterization in 19 South-Italian patients with dominant and recessive type of myotonia congenita. Front Neurol. 2020;11:63.
  • Fialho D, Schorge S, Pucovska U, et al. Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain. 2007;130(Pt 12):3265–3274.
  • Sasaki R, Nakaza M, Furuta M, et al. Mutation spectrum and health status in skeletal muscle channelopathies in Japan. Neuromuscul Disord. 2020;30(7):546–553.
  • Miao J, Wei XJ, Liu XM, et al. A case report: autosomal recessive Myotonia congenita caused by a novel splice mutation (c.1401+1G>A) in CLCN1 gene of a Chinese Han patient. BMC Neurol. 2018;18(1):154.
  • Meyer-Kleine C, Steinmeyer K, Ricker K, et al. Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia. Am J Hum Genet. 1995;57(6):1325–1334.
  • Meng YX, Zhao Z, Shen HR, et al. Identification of novel mutations of the CLCN1 gene for myotonia congenital in China. Neurol Res. 2016;38(1):40–44.
  • Esteban J, Neumeyer AM, McKenna-Yasek D, et al. Identification of two mutations and a polymorphism in the chloride channel CLCN-1 in patients with Becker’s generalized myotonia. Neurogenetics. 1998;1(3):185–188.
  • Zhang J, George AL Jr., Griggs RC, et al. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology. 1996;47(4):993–998.
  • Duno M, Colding-Jorgensen E, Grunnet M, et al. Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype. Eur J Hum Genet. 2004;12(9):738–743.
  • Milla CP, De Castro CP, Gomez-Gonzalez C, et al. Myotonia congenita: mutation spectrum of CLCN1 in Spanish patients. J Genet. 2019;98:98.
  • Brugnoni R, Kapetis D, Imbrici P, et al. A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene. J Hum Genet. 2013;58(9):581–587.
  • Skalova D, Zidkova J, Vohanka S, et al. CLCN1 mutations in Czech patients with myotonia congenita, in silico analysis of novel and known mutations in the human dimeric skeletal muscle chloride channel. PLoS One. 2013;8(12):e82549.
  • Koty PP, Pegoraro E, Hobson G, et al. Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect. Neurology. 1996;47(4):963–968.